Ehlers M R, Schwager S L, Chubb A J, Scholle R R, Brandt W F, Riordan J F
Department of Medical Biochemistry, University of Cape Town Medical School, South Africa.
Immunopharmacology. 1997 Jun;36(2-3):271-8. doi: 10.1016/s0162-3109(97)00032-5.
Diverse membrane proteins are solubilized by a specific proteolytic cleavage in the stalk sequence adjacent to the membrane anchor, with release of the extracellular domain. Examples are the amyloid precursor protein, membrane-bound growth factors and angiotensin-converting enzyme (ACE). The identities and characteristics of the responsible proteases remain elusive. We have studied this process in Chinese hamster ovary (CHO) cells stably expressing wild-type ACE (WT-ACE) or juxtamembrane (stalk) deletion or chimaera mutants. Determination of the C termini (i.e. the cleavage sites) of released, soluble wild-type and mutant ACE by MALDI-TOF mass spectrometry indicated that the membrane-protein-solubilizing protease (MPSP) in CHO cells is not constrained by a particular cleavage site motif or by a specific distance from the membrane, but instead may position itself with respect to the putative proximal, folded extracellular domain adjacent to the stalk. Nevertheless, kinetic analyses of release rates indicated that a minimum distance from the membrane must be preserved. Interestingly, soluble full-length (anchor-plus) WT-ACE incubated with fractions of, or intact, CHO cells was not cleaved. In all cases, release was stimulated by a media change or by the addition of phorbol ester, with rate enhancements of 5- and 50-fold, respectively, for WT-ACE. The phorbol ester effect was abolished by staurosporine, a protein kinase C (PKC) inhibitor. We propose that the CHO cell MPSP that solubilizes ACE: (1) only cleaves proteins embedded in a membrane; (2) requires an accessible stalk and cleaves at a minimum distance from both the membrane and proximal extracellular domain; (3) positions itself primarily with respect to the proximal extracellular domain and (4) is regulated in part by a PKC-dependent mechanism.
多种膜蛋白通过在与膜锚定相邻的柄序列中进行特定的蛋白水解切割而溶解,同时释放细胞外结构域。例如淀粉样前体蛋白、膜结合生长因子和血管紧张素转换酶(ACE)。负责的蛋白酶的身份和特征仍然难以捉摸。我们在中国仓鼠卵巢(CHO)细胞中研究了这一过程,这些细胞稳定表达野生型ACE(WT-ACE)或近膜(柄)缺失或嵌合突变体。通过基质辅助激光解吸电离飞行时间质谱法(MALDI-TOF)测定释放的可溶性野生型和突变型ACE的C末端(即切割位点)表明,CHO细胞中的膜蛋白溶解蛋白酶(MPSP)不受特定切割位点基序或与膜的特定距离的限制,而是可能相对于与柄相邻的假定近端折叠细胞外结构域定位自身。然而,释放速率的动力学分析表明,必须保持与膜的最小距离。有趣的是,与CHO细胞的部分或完整部分一起孵育的可溶性全长(加锚定)WT-ACE没有被切割。在所有情况下,培养基更换或添加佛波酯都会刺激释放,对于WT-ACE,释放速率分别提高5倍和50倍。佛波酯的作用被蛋白激酶C(PKC)抑制剂星形孢菌素消除。我们提出,溶解ACE的CHO细胞MPSP:(1)仅切割嵌入膜中的蛋白质;(2)需要一个可及的柄,并在距膜和近端细胞外结构域的最小距离处切割;(3)主要相对于近端细胞外结构域定位自身;(4)部分受PKC依赖性机制调节。